- Home
- VIST vs RNA Comparison
VIST vs RNA Comparison
Compare VIST & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIST
- RNA
- Stock Information
- Founded
- VIST 2017
- RNA 2012
- Country
- VIST Mexico
- RNA United States
- Employees
- VIST N/A
- RNA N/A
- Industry
- VIST Oil & Gas Production
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- VIST Energy
- RNA Health Care
- Exchange
- VIST Nasdaq
- RNA Nasdaq
- Market Cap
- VIST 5.2B
- RNA 4.4B
- IPO Year
- VIST 2019
- RNA 2020
- Fundamental
- Price
- VIST $51.03
- RNA $29.31
- Analyst Decision
- VIST Strong Buy
- RNA Strong Buy
- Analyst Count
- VIST 4
- RNA 14
- Target Price
- VIST $65.75
- RNA $68.00
- AVG Volume (30 Days)
- VIST 669.6K
- RNA 1.4M
- Earning Date
- VIST 07-10-2025
- RNA 08-08-2025
- Dividend Yield
- VIST N/A
- RNA N/A
- EPS Growth
- VIST 33.67
- RNA N/A
- EPS
- VIST 4.66
- RNA N/A
- Revenue
- VIST $1,768,872,000.00
- RNA $8,927,000.00
- Revenue This Year
- VIST $25.99
- RNA N/A
- Revenue Next Year
- VIST $19.89
- RNA $155.06
- P/E Ratio
- VIST $11.23
- RNA N/A
- Revenue Growth
- VIST 51.32
- RNA N/A
- 52 Week Low
- VIST $32.11
- RNA $21.51
- 52 Week High
- VIST $61.67
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- VIST 53.58
- RNA 42.04
- Support Level
- VIST $47.61
- RNA $31.59
- Resistance Level
- VIST $55.20
- RNA $38.00
- Average True Range (ATR)
- VIST 1.85
- RNA 2.01
- MACD
- VIST -0.04
- RNA -0.59
- Stochastic Oscillator
- VIST 45.06
- RNA 9.67
About VIST Vista Energy S.A.B. de C.V. each representing one series A share with no par value
Vista Energy SAB de CV is an independent oil and gas company. It is focused on shale oil and shale gas exploration at its main assets in Vaca Muerta. The company has operations in Argentina and Mexico. The company operates in a single segment- the exploration and production of Crude oil, Natural gas, and LPG. Geographically, It operates in Argentina and Mexico. it generates the majority of its revenue from Argentina.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.